| Name | Title | Contact Details |
|---|
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Sebo Tek Hearing Systems is a Tulsa, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
New Century Health delivers specialty care management solutions that leverage technology and evidence-based medicine at the point-of-care, with a focus on oncology and cardiology. Our services promote the most effective treatment, reduce variability, improve clinical outcomes, and optimize cost-effectiveness.
Washington Hospital Healthcare System is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Washington Hospital Healthcare System is based in Fremont, CA. You can find more information on Washington Hospital Healthcare System at www.whhs.com
Access Medical Associates is a Englewood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.